Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€315.80

€315.80

-0.190%
-0.6
-0.190%
€341.27
 
23.08.24 / Tradegate WKN: 864952 / Symbol: SYK / Name: Stryker / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Stryker Corp. Stock

The price for the Stryker Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.600 (-0.190%).
With 30 Buy predictions and not a single Sell prediction Stryker Corp. is an absolute favorite of our community.
With a target price of 341 € there is a slightly positive potential of 7.98% for Stryker Corp. compared to the current price of 315.8 €.

Pros and Cons of Stryker Corp. in the next few years

Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Stryker Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Stryker Corp. -0.190% 3.001% 0.286% 24.331% 17.050% 39.858% 64.359%
Dexcom Inc. 1.410% -2.274% -35.971% -31.127% -40.890% -39.340% 69.932%
Dentsply Sirona Inc. 1.110% -2.204% -5.826% -34.896% -29.677% -55.714% -51.234%
Zimmer Holdings 0.450% 1.997% 0.789% -4.309% -7.136% -17.455% -17.621%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

The financial performance of Stryker Corporation (SYK) in the Healthcare Equipment & Supplies industry presents a mixed bag of strengths and weaknesses. The company has showcased significant growth in revenues and net income over the past few years, demonstrating resilience in an evolving market. However, challenges related to profitability margins and high valuation ratios suggest a careful approach to investment. Let’s delve deeper into the key components of the financials to get a clearer picture of Stryker’s financial health.

*Pros: *

Revenue Growth: Stryker exhibited robust revenue growth year-over-year, going from $17.1 billion in 2021 to approximately $20.5 billion in 2023. This growth can be attributed to increasing demand for medical devices, innovations, and the company’s broad product portfolio, which includes surgical equipment, neurotechnology, and spine products.

Comments

Prediction Buy
Perf. (%) 2.57%
Target price 372.533
Change
Ends at 01.08.25

Stryker Co. (NYSE: SYK) had its price target raised by analysts at Barclays PLC from $374.00 to $402.00. They now have an "overweight" rating on the stock.
Ratings data for SYK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 4.33%
Target price 363.918
Change
Ends at 01.08.25

Stryker Co. (NYSE: SYK) had its price target raised by analysts at Needham & Company LLC from $392.00 to $393.00. They now have a "buy" rating on the stock.
Ratings data for SYK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 4.57%
Target price 332.424
Change
Ends at 31.07.25

Stryker Co. (NYSE: SYK) had its price target lowered by analysts at BTIG Research from $372.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for SYK provided by MarketBeat
Show more

News

Medical Technology Stock Benefits from Rising Acute Care Demand: https://www.marketbeat.com/logos/articles/med_20240804190513_chartg-syk.jpg
Medical Technology Stock Benefits from Rising Acute Care Demand

Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. Acute care is considered short-term intensive